- Home
- CERO vs OP Comparison
CERO vs OP Comparison
Compare CERO & OP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CERO
- OP
- Stock Information
- Founded
- CERO 2017
- OP 2021
- Country
- CERO United States
- OP Greece
- Employees
- CERO N/A
- OP N/A
- Industry
- CERO
- OP
- Sector
- CERO
- OP
- Exchange
- CERO Nasdaq
- OP Nasdaq
- Market Cap
- CERO 8.4M
- OP 8.5M
- IPO Year
- CERO N/A
- OP N/A
- Fundamental
- Price
- CERO $1.85
- OP $1.13
- Analyst Decision
- CERO
- OP
- Analyst Count
- CERO 0
- OP 0
- Target Price
- CERO N/A
- OP N/A
- AVG Volume (30 Days)
- CERO 764.0K
- OP 11.1K
- Earning Date
- CERO 02-20-2025
- OP 12-20-2024
- Dividend Yield
- CERO N/A
- OP N/A
- EPS Growth
- CERO N/A
- OP N/A
- EPS
- CERO N/A
- OP N/A
- Revenue
- CERO N/A
- OP $25,729,000.00
- Revenue This Year
- CERO N/A
- OP N/A
- Revenue Next Year
- CERO N/A
- OP N/A
- P/E Ratio
- CERO N/A
- OP N/A
- Revenue Growth
- CERO N/A
- OP 36.33
- 52 Week Low
- CERO $1.75
- OP $1.02
- 52 Week High
- CERO $1,238.00
- OP $3.15
- Technical
- Relative Strength Index (RSI)
- CERO 33.10
- OP 40.22
- Support Level
- CERO $1.77
- OP $1.11
- Resistance Level
- CERO $2.22
- OP $1.24
- Average True Range (ATR)
- CERO 0.36
- OP 0.05
- MACD
- CERO 0.28
- OP -0.00
- Stochastic Oscillator
- CERO 6.99
- OP 7.17
About CERO CERo Therapeutics Holdings Inc. Common Stock
CERo Therapeutics Holdings Inc is an innovative immunotherapy company advancing the development of next-generation engineered T-cell therapeutics for the treatment of cancer. Its proprietary approach to T cell engineering, which enables it to integrate certain desirable characteristics of both innate and adaptive immunity into a single therapeutic construct, is designed to engage the body's full immune repertoire to achieve optimized cancer therapy.
About OP OceanPal Inc.
OceanPal Inc is a provider of shipping transportation services. It specializes in the ownership of vessels. Each of its vessels is owned through a separate wholly-owned subsidiary.